Sort
51,593 grants matching “hepatitis”
Immune suppressor mechanism in a murine model of hepatitis and liver cancer
$432,799Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
NOVEL APPROACHES FOR REGULATION OF IGF-1 LEVELS THROUGHOUT THE LIFESPAN
$432,777William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2015 · AG
The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis
$432,709Xiao-Ming Yin · Indiana University Indianapolis · R01 · FY2013 · AA
Novel therapy targeting refractory colon cancer
$432,692Ping-Ying Pan · Methodist Hospital Research Institute · R01 · FY2018 · CA
GENETIC ANALYSIS OF CORONAVIRUS ASSEMBLY INTERACTIONS
$432,664Paul Scott Masters · Wadsworth Center · R01 · FY2009 · AI
Immunoregulation of schistosomiasis
$432,633Miguel J. Stadecker · Tufts University Boston · R01 · FY2013 · AI
Surgery triggered immune response and liver metastases
$432,629Allan Tsung · University Of Virginia · R01 · FY2023 · CA
Technologies and Resources for Core Laboratories
$432,608Laura F Gibson · West Virginia University · U54 · FY2017 · GM
HEPATIC ORGANIC ANION UPTAKE TRANSPORT
$432,572Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2007 · DK
Novel action of grape skin components on postprandial hyperglycemia
$432,553Kequan Zhou · Wayne State University · R01 · FY2016 · AT
Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors
$432,549E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2024 · AI
Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors
$432,549E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2021 · AI
Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors
$432,549E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2023 · AI
Regulation of Rotavirus Replication
$432,549Mary Kolb Estes · Baylor College Of Medicine · R56 · FY2014 · AI
HEPATIC ORGANIC ANION UPTAKE TRANSPORT
$432,513Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2006 · DK
Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk
$432,500John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2021 · DK
ApoJ as a novel hepatokine targeting muscle glucose metabolism
$432,500Young-Bum Kim · Beth Israel Deaconess Medical Center · R01 · FY2019 · DK
ApoJ as a novel hepatokine targeting muscle glucose metabolism
$432,500Young-Bum Kim · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK
Novel Therapy for Amyotrophic Lateral Sclerosis
$432,496David E Smith · Angion Biomedica Corporation · R44 · FY2010 · NS
GENE THERAPY FOR DYSLIPIDEMIAS
$432,414Daniel James Rader · University Of Pennsylvania · P01 · FY2010 · HL
Novel coagulation-dependent mechanisms of liver regeneration to detect and prevent liver dysfunction after partial hepatectomy
$432,401James P Luyendyk · Michigan State University · R01 · FY2020 · DK
Role of neutrophil-specific NOX2 in alcohol-induced liver injury
$432,387Cynthia Ju · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · AA
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR
$432,304Gerardo M. Castillo · Pharmain Corporation · R44 · FY2011 · AA
CONTROL OF CELL FUNCTION VIA SELECTIVE MRNA TRANSLATION
$432,287Massachusetts Institute Of Technology · R01 · FY2002 · GM
Core J: Virology and Molecular Biomarkers Core
$432,284Guido Silvestri · Emory University · P30 · FY2021 · AI